trending Market Intelligence /marketintelligence/en/news-insights/trending/2bi6tAHYmH9NRDOyj1_5zg2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Oncimmune replaces outgoing CFO

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity


Oncimmune replaces outgoing CFO

Oncimmune Holdings PLC director and CFO Andrew Millet has stepped down but will remain with the company for six months to ensure an orderly transition.

The company appointed Matthew Hall to replace Millet. Hall recently served as CFO at Tusk Therapeutics and Simbec-Orion Group.

Oncimmune is an early-cancer detection company.